|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Non-cash interest and investment income | |||||
| Patent write-offs | |||||
| Non-cash loss on disposal of assets | |||||
| Other | |||||
| Operating lease right-of-use asset amortization | |||||
| Finance lease right-of-use asset amortization | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaids and other current assets | |||||
| Other assets | |||||
| Deferred taxes | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accrued salaries and payroll related expenses | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Deferred rent | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Proceeds from sale of property and equipment | |||||
| Purchases of property and equipment | |||||
| Expenditures for patents | |||||
| Redemptions of investments held-to-maturity | |||||
| Purchases of investments held-to-maturity | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Net proceeds from the sale of common stock from underwritten public offering | |||||
| Acquisition of common stock under repurchase program | |||||
| Offering costs in connection with the sale of common stock | |||||
| Proceeds from exercises of warrants | |||||
| Principal payments on finance lease | |||||
| Proceeds from exercises of stock options | |||||
| Net cash provided by financing activities | |||||
| Cash and cash equivalents | |||||
| Effects of currency translation on cash, cash equivalents and restricted cash | |||||
| NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of year | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH — End of year | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||||
| Cash paid for taxes | |||||
| Cash paid for interest | |||||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES | |||||
| Common stock issued in settlement of accrued salaries and payroll related expenses | |||||
| Property and equipment included in accounts payable | |||||
| Property and equipment included in accrued expenses | |||||
| Patents included in accounts payable | |||||
| Finance lease liability included in accounts payable | |||||
| Property acquired through finance lease obligation | |||||
| Operating lease assets obtained in exchange for new lease liabilities | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...